OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
OptimizeRx (Nasdaq: OPRX), a leading provider of healthcare technology solutions, has scheduled its first quarter 2025 earnings conference call for Monday, May 12, 2025, at 4:30 p.m. Eastern Time. The company will release its financial results for the period ended March 31, 2025, via press release before the call.
The conference call will include a management presentation followed by a Q&A session. Investors can join through multiple channels including toll-free (1-844-825-9789) and international (1-412-317-5180) numbers. A webcast option is also available, and the replay will be accessible for 12 months through the company's investor relations website.
OptimizeRx (Nasdaq: OPRX), un fornitore leader di soluzioni tecnologiche per la sanità, ha programmato la conference call per la presentazione dei risultati del primo trimestre 2025 per lunedì 12 maggio 2025 alle 16:30 ora Eastern. L'azienda pubblicherà i risultati finanziari relativi al periodo terminato il 31 marzo 2025 tramite un comunicato stampa prima della chiamata.
La conference call comprenderà una presentazione del management seguita da una sessione di domande e risposte. Gli investitori potranno partecipare attraverso diversi canali, inclusi numeri verdi (1-844-825-9789) e numeri internazionali (1-412-317-5180). Sarà disponibile anche una diretta web, e la registrazione resterà accessibile per 12 mesi sul sito web delle relazioni con gli investitori dell’azienda.
OptimizeRx (Nasdaq: OPRX), un proveedor líder de soluciones tecnológicas para el sector salud, ha programado su llamada de conferencia para los resultados del primer trimestre de 2025 para el lunes 12 de mayo de 2025 a las 4:30 p.m. hora del Este. La empresa publicará sus resultados financieros correspondientes al periodo finalizado el 31 de marzo de 2025 mediante un comunicado de prensa antes de la llamada.
La llamada incluirá una presentación de la dirección seguida de una sesión de preguntas y respuestas. Los inversionistas podrán unirse a través de varios canales, incluyendo números gratuitos (1-844-825-9789) y números internacionales (1-412-317-5180). También habrá una opción de webcast, y la repetición estará disponible durante 12 meses en el sitio web de relaciones con inversionistas de la compañía.
OptimizeRx (나스닥: OPRX)는 선도적인 헬스케어 기술 솔루션 제공업체로서 2025년 1분기 실적 컨퍼런스 콜을 2025년 5월 12일 월요일 동부시간 오후 4시 30분에 예정하고 있습니다. 회사는 2025년 3월 31일 종료된 기간의 재무 결과를 콜 전에 보도자료를 통해 발표할 예정입니다.
컨퍼런스 콜은 경영진 발표와 이어지는 질의응답 세션으로 구성됩니다. 투자자들은 무료 전화(1-844-825-9789) 및 국제 전화(1-412-317-5180)를 포함한 여러 채널을 통해 참여할 수 있습니다. 웹캐스트 옵션도 제공되며, 녹화본은 회사 투자자 관계 웹사이트를 통해 12개월간 다시보기 가능합니다.
OptimizeRx (Nasdaq : OPRX), un fournisseur leader de solutions technologiques pour la santé, a programmé sa conférence téléphonique sur les résultats du premier trimestre 2025 pour le lundi 12 mai 2025 à 16h30 heure de l’Est. La société publiera ses résultats financiers pour la période close au 31 mars 2025 par communiqué de presse avant la conférence.
La conférence téléphonique comprendra une présentation de la direction suivie d’une session de questions-réponses. Les investisseurs pourront participer via plusieurs canaux, y compris des numéros gratuits (1-844-825-9789) et des numéros internationaux (1-412-317-5180). Une option de webdiffusion sera également disponible, et le replay sera accessible pendant 12 mois sur le site des relations investisseurs de la société.
OptimizeRx (Nasdaq: OPRX), ein führender Anbieter von Gesundheitstechnologielösungen, hat seine Telefonkonferenz zur Veröffentlichung der Ergebnisse für das erste Quartal 2025 für Montag, den 12. Mai 2025, um 16:30 Uhr Eastern Time angesetzt. Das Unternehmen wird die Finanzergebnisse für den Zeitraum bis zum 31. März 2025 vor der Telefonkonferenz per Pressemitteilung veröffentlichen.
Die Telefonkonferenz umfasst eine Präsentation des Managements, gefolgt von einer Fragerunde. Investoren können über verschiedene Kanäle teilnehmen, darunter gebührenfreie Nummern (1-844-825-9789) und internationale Nummern (1-412-317-5180). Es steht auch eine Webcast-Option zur Verfügung, und die Aufzeichnung ist für 12 Monate über die Investor-Relations-Website des Unternehmens abrufbar.
- None.
- None.
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Monday, May 12, 2025, at 4:30 p.m. Eastern Time to discuss its results for the first quarter period ended March 31, 2025. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Monday, May 12, 2025 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10198829 |
| Call me™ Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Call me™ Passcode: | 8199416 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1715418&tp_key=2f5165024a |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life sciences engage with customers.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
shalper@lifesciadvisors.com
FAQ
When is OptimizeRx (OPRX) reporting Q1 2025 earnings?
How can investors access OptimizeRx's Q1 2025 earnings call?
How long will OptimizeRx's Q1 2025 earnings call replay be available?
What time does OPRX Q1 2025 earnings call start in Pacific Time?
